Serum inflammatory markers as predictors of therapeutic response in non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease: a retrospective cohort analysis
Patients with non-IPF f-ILD and elevated inflammatory markers appear to be more responsive to anti-inflammatory therapy with slower FVC decline over time. These findings suggest baseline serum ESR and CRP may be feasible and reliable predictors of treatment response in certain subgroups.
Authors
- Yanisa Kluanwan (ORCID: https://orcid.org/0000-0002-5875-5137)
- Teng Moua (ORCID: https://orcid.org/0000-0003-3329-5717)
Institutions
- Mayo Clinic (US)
- Central Chest Institute of Thailand (TH)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1186/s12890-025-03703-z
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00